{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:15:48Z","timestamp":1781842548776,"version":"3.54.5"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T00:00:00Z","timestamp":1394064000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0090047","type":"journal-article","created":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T16:40:22Z","timestamp":1394124022000},"page":"e90047","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["Macrolide Therapy in Adults and Children with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and Meta-Analysis"],"prefix":"10.1371","volume":"9","author":[{"given":"Yong-hua","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-jie","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-ya","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-min","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-shan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,6]]},"reference":[{"issue":"Suppl 1","key":"ref1","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2010.136119","article-title":"British Thoracic Society guideline for non-CF bronchiectasis","volume":"65","author":"MC Pasteur","year":"2010","journal-title":"Thorax"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/thoraxjnl-2012-202893","article-title":"Research priorities in bronchiectasis","volume":"68","author":"A De Soyza","year":"2013","journal-title":"Thorax"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e71109","DOI":"10.1371\/journal.pone.0071109","article-title":"Bronchiectasis-associated hospitalizations in Germany, 2005\u20132011: a population-based study of disease burden and trends","volume":"8","author":"FC Ringshausen","year":"2013","journal-title":"PLoS ONE"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1378\/chest.10-0099","article-title":"Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993\u20132006","volume":"138","author":"AE Seitz","year":"2010","journal-title":"Chest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1378\/chest.11-2209","article-title":"Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007","volume":"142","author":"AE Seitz","year":"2012","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/adc.2004.066472","article-title":"New Zealand national incidence of bronchiectasis \u201ctoo high\u201d for a developed country","volume":"90","author":"J Twiss","year":"2005","journal-title":"Arch Dis Child"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0954-6111(97)90251-1","article-title":"Bronchiectasis in Finland: trends in hospital treatment","volume":"91","author":"O Saynajakangas","year":"1997","journal-title":"Respir Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/jac\/dkr040","article-title":"Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review","volume":"66","author":"Y Cai","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/all.12199","article-title":"Macrolides for the long-term management of asthma - a meta-analysis of randomized clinical trials","volume":"68","author":"J Reiter","year":"2013","journal-title":"Allergy"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1183\/09031936.00136712","article-title":"Long-term macrolide treatment for chronic respiratory disease","volume":"42","author":"P Spagnolo","year":"2013","journal-title":"Eur Respir J"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","article-title":"Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin","volume":"157","author":"S Kudoh","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/TP.0b013e3181a492b2","article-title":"Long-term clarithromycin therapy in the management of lung transplant recipients","volume":"87","author":"C Benden","year":"2009","journal-title":"Transplantation"},{"key":"ref13","article-title":"Macrolide Therapy Decreases Chronic Obstructive Pulmonary Disease Exacerbation: A Meta-Analysis","author":"GY Yao","year":"2013","journal-title":"Respiration"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CMR.00078-09","article-title":"Mechanisms of action and clinical application of macrolides as immunomodulatory medications","volume":"23","author":"S Kanoh","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial","volume":"309","author":"DJ Serisier","year":"2013","journal-title":"JAMA"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"J Altenburg","year":"2013","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fi brosis bronchiectasis (EMBRACE): A randomised, double-blind, placebo-controlled trial","volume":"380","author":"C Wong","year":"2012","journal-title":"The Lancet"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Evans DJ, Bara AI, Greenstone M (2007) Prolonged antibiotics for purulent bronchiectasis in children and adults. Cochrane Database Syst Rev: CD001392.","DOI":"10.1002\/14651858.CD001392.pub2"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary","volume":"17","author":"AR Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"JP Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1183\/09031936.97.10050994","article-title":"Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study","volume":"10","author":"YY Koh","year":"1997","journal-title":"Eur Respir J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1183\/09031936.99.13236199","article-title":"A pilot study of low-dose erythromycin in bronchiectasis","volume":"13","author":"KW Tsang","year":"1999","journal-title":"Eur Respir J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00151829-200504020-00005","article-title":"The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis","volume":"4","author":"AA Cymbala","year":"2005","journal-title":"Treat Respir Med"},{"key":"ref24","first-page":"044","article-title":"Lack of efficacy of an immunomodulatory macrolide in childhood HIV related bronchiectasis: A randomised, placebo-controlled trial","volume":"5","author":"R Masekela","year":"2013","journal-title":"J Antivir Antiretrovir"},{"key":"ref25","article-title":"Effects of Long-term Azithromycin Therapy on Airway Oxidative Stress Markers in non-Cystic Fibrosis bronchiectasis","author":"A de Diego","year":"2013","journal-title":"Respirology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S2213-2600(13)70185-1","article-title":"Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial","volume":"1","author":"PC Valery","year":"2013","journal-title":"Lancet Respir Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1183\/09031936.06.00131805","article-title":"Diffuse panbronchiolitis","volume":"28","author":"V Poletti","year":"2006","journal-title":"Eur Respir J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis","volume":"186","author":"JD Chalmers","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1164\/rccm.200305-648OC","article-title":"Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease","volume":"170","author":"IS Patel","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1081\/COPD-200050513","article-title":"St. George's Respiratory Questionnaire: MCID","volume":"2","author":"PW Jones","year":"2005","journal-title":"COPD"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"MA Martinez-Garcia","year":"2007","journal-title":"Chest"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/ajrccm.156.2.9607083","article-title":"Validation of the St. George's Respiratory Questionnaire in bronchiectasis","volume":"156","author":"CB Wilson","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S2213-2600(13)70038-9","article-title":"Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases","volume":"1","author":"DJ Serisier","year":"2013","journal-title":"Lancet Respir Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"WA Ray","year":"2012","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"f1235","DOI":"10.1136\/bmj.f1235","article-title":"Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies","volume":"346","author":"S Schembri","year":"2013","journal-title":"BMJ"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0090047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T22:52:03Z","timestamp":1540248723000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0090047"}},"subtitle":[],"editor":[{"given":"Michael","family":"Tunney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,6]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0090047","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,6]]}}}